Sie weiterhin diese Meldung erhalten, informieren Sie uns darber bitte per E-Mail Mr. Fenimore is a Certified Public Accountant in the state of New York. Prior to joining Regeneron, Dr. Macdonald worked for Cadus Pharmaceuticals after completing a post-doctoral fellowship at Columbia University. in Science from the University of California, Davis. $822.8K. Dr. Weinreich received his B.S. Dr. Bassler currently serves on the board of directors of Kaleido Biosciences, Inc., Cidara Therapeutics, Inc. and Royalty Pharma plc. Based on 12 salaries posted anonymously by AstraZeneca Vice President Finance employees in Cannock, England. Mr. Brooks received both a B.S. Be the first to add REGENERON PHARMACEUTICALS, INC. Vice President of Human Resources responsibilities. On Fishbowl, you can share insights and advice anonymously with Regeneron employees and get real answers from people on the inside. Prior to that she was chief diversity officer for Dow Jones, including its flagship brand, The Wall Street Journal. from Harvard University and her J.D. Brian Zambrowicz, Ph.D., joined Regeneron in 2015 and serves as executive vice president, functional genomics and chief, VelociGene operations. Frederick Austin joined Regeneron in 2012 and serves as senior vice president, quality control, Raheen. Dr. Murphy is a co-inventor of several of Regeneron's key technologies, VelociGene and VelocImmune, and continues to lead several technology centers and therapeutic focus areas. Prior to joining Regeneron, Dr. Morton completed post-doctoral fellowships at Pfizer and Sloan Kettering Cancer Center. Dr. Lin received his M.D. Dr. Brown is a member of the National Academy of Sciences, the National Academy of Medicine and the Royal Society of London. Based on 1 salaries posted anonymously by PDR Network Vice President Business Development employees in West Point, PA. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Dr. Weinreich was previously the Senior Vice President and head of global development for specialty medicine at Bayer Pharmaceuticals. Christina holds an MBA in finance and strategy from the Stern School of Business at New York University and a B.A. David Weinreich, M.D., joined Regeneron in 2016 and serves as executive vice president, global clinical development. Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Dr. Yancopoulos is currently president and chief scientific officer, and has been a director of the company since 2001. Executive Vice President, General Counsel and Secretary. Abbvie The average salary for a Vice President is $172,519 per year in United States, which is 59% lower than the average Regeneron salary of $420,792 per year for this job. He is responsible for protecting Regenerons intellectual property, including by developing and implementing a comprehensive global IP strategy. Dr. Tessier-Lavigne is also a member of the board of directors of Denali Therapeutics Inc. President Emeritus of Memorial SloanKettering Cancer Center. Mr. Berkovic earned his B.S. Of this total $724,500 was received as a salary, $819,410 was received as a bonus, $3,347,323 was received in stock options, $2,231,397 was awarded as stock and $24,200 came from other types of compensation. in neuroscience from New York University. Before joining Regeneron, he was at Progenics Pharmaceuticals for 19 years. In her role, Dr. Morton has led the discovery and development of a highly innovative and diverse portfolio across disease areas. He is also a regental professor of molecular genetics and internal medicine and the director of the Jonsson Center for Molecular Genetics at the UT Southwestern Medical Center at Dallas, positions he has held since 1985. Co-Founder, President and Chief Executive Officer, Co-Founder, President and Chief Scientific Officer, Senior Vice President, Financial Planning and Analysis. Highest Paying Job At Regeneron In Rensselaer, NY Medical Director - $261,089 See Other Titles Highest Paying Department At Regeneron In Rensselaer, NY $115,622 See Other Departments Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. As Executive Vice President and General Manager, Industrial Operations and Product Supply at REGENERON PHARMACEUTICALS, INC., Daniel Van Plew made $8,978,600 in total compensation. Se continui a visualizzare The estimated total pay for a Vice President at Regeneron is $420,792 per year. He earned his B.S. Regeneron employees rate the overall compensation and benefits package 4.2/5 stars. Mr. and B.S. Prior to joining Regeneron, Ms. Bermingham held roles of increasing responsibility at PhRMA over a 12 year tenure, following earlier positions at legal firms, and work for Senator Moynihan and the Senate Finance Committee. The estimated total pay for a Vice President Operations at Regeneron is $448,608 per year. Leonard (Len) Brooks joined Regeneron in 2013 and serves as senior vice president, treasurer. He also is a member of the boards of trustees of The Rockefeller University and the Howard Hughes Medical Institute. Prior to joining Regeneron, Mr. Brooks worked in public accounting at Deloitte before moving to treasury, where he held various positions of increasing responsibility at both mid- and large-sized companies, including Wyeth, Medco Health Solutions, Reliant Pharmaceuticals, The Childrens Place and Hayward Industries. The site you are about to visit is maintained by a third party who is solely responsible for its content. and Ph.D. from the University of Wales in the UK. The estimated total pay for a Vice President at Regeneron is $419,353 per year. . , REGENERON PHARMACEUTICALS, INC. annual reports of executive compensation and pay are most commonly found in the Def 14a documents. He previously served as the regional CFO for Japan, Australia and New Zealand at Mylan, as well as other roles, and he worked at Cephalon in financial roles. He has served as the president and chief executive officer of Cerevel Therapeutics Holdings, Inc., the parent entity of Cerevel Therapeutics, Inc. since 2019, and as chair of Cerevel Therapeutics Holdings, Inc. since 2018. Please help us protect Glassdoor by verifying that you're a Prior to joining Regeneron, Dr. Merino was an associate general counsel at Columbia University and a patent attorney at Bryan Cave LLP in New York City. Dr. Bassler has previously served as the president of the American Society for Microbiology, as well as on the boards for the American Association for the Advancement of Science, the National Science Foundation and the American Academy of Microbiology. Read what they think about their salaries on our Compensation FAQ page for Regeneron. from the United States Air Force Academy and her M.A. He is a physician-scientist with decades of experience in design, execution and analysis of clinical trials. naar Previously, Dr. Geba worked at Sanofi, AstraZeneca, Novartis, Merck and Yale University as an assistant professor of medicine. He earned his B.S. in marketing at Auburn University and his MBA at New York University. Well-versed in leave administration The VP you'll be reporting to has a collaborative leadershipof Monday, February 13th. Regeneron Pharmaceuticals: Delivering Life-transforming Medicines Push the bounds of science Make life-changing medicines Pause Regeneron News: Feb 23rd Aflibercept 8 mg BLA for Treatment of Wet Age-Related Macular Degeneration and Diabetic Macular Edema Accepted for FDA Priority Review Follow us: Now approved for a new indication Now approved for Robert Vitti, MD Vice President, Clinical Sciences Ophthalmology Alyson Berliner, MD, PhD Executive Director, Ophthalmology October 11, 2019 Robert (Bob) Vitti and Alyson Berliner sit down to discuss their motivations for studying diabetic retinopathy (DR) and how their job was to shift the mindset around the disease. The base salary for Senior Vice President of Operations in companies like REGENERON PHARMACEUTICALS range from $374,801 to $560,101 with the average base salary of $457,501. For its 2021 fiscal year, REGENERON PHARMACEUTICALS, INC., listed the following CEO pay ratio data on its annual proxy statement to the SEC. Overall Benefits Rating.css-11cfy92{color:#0caa41 !important;}.css-11cfy92{color:#0caa41 !important;}4.1, Matches half of your contribution up to 5% (of gross pay) on 10%. The average Regeneron salary ranges from approximately $52,103 per year for a Research Assistant to $376,244 per year for a Senior Director. On Fishbowl, you can share insights and advice anonymously with Regeneron employees and get real answers from people on the inside. Gonzalo Merino, Ph.D., J.D., joined Regeneron in 2013 and now serves as senior vice president and chief intellectual property counsel. Mr. Van Plew received his M.S. Als u dit bericht blijft zien, stuur dan een e-mail The charts on this page feature a breakdown of the total annual pay for the top executives at REGENERON PHARMACEUTICALS, INC. as reported in their proxy statements. Si continas recibiendo este mensaje, infrmanos del problema Chris Fenimore joined Regeneron in 2003 and, as the current head of accounting and controller, has global responsibility for SEC reporting,accounting and accounting operations, and internal control over financial reporting, administration of financial systems, accounts payableandpayroll. He has held leadership roles in quality, validation, regulatory, internal manufacturing and engineering. Gregory Geba, M.D., Ph.D., joined Regeneron in 2013 and serves as senior vice president of the global development scientific council, a group that provides senior scientific input to Regenerons therapeutic portfolio of programs. Senior Vice President, IT and Chief Information Officer. Mr. McCowan previously worked at international organizations including Amgen, Artemis International, Computer Science Corporation and Lockheed. The Role Reporting to the company's CEO/CFO, the Vice President of Finance, Controller is a VP-level manager who leads the company's accounting and financial reporting functions and sits on the six OpenGov - San Jose Regeneron Pharmaceuticals Vice-president average salary is $-, median salary is $- with a salary range from $- to $-. Executive Vice President, Regulatory Affairs and Global Patient Safety. A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The information shown here is a reporting of information included in the company's proxy statement. BMS For its 2021 fiscal year, REGENERON PHARMACEUTICALS, INC., listed the following board members on its annual proxy statement to the SEC. Regeneron is an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion or belief (or lack thereof), sex,. Vice President of Operations yearly salaries in the United States at Regeneron Job Title Vice President of Operations Location United States Low confidence Estimated average pay $112,836 per year 23% Below national average Average $112,836 Low $104,937 High $126,376 Gerald Carreau joined Regeneron in 2008 and serves as senior vice president, commercial scale manufacturing and manufacturing technology. Takeda The total cash compensation, which includes bonus, and annual incentives, can vary anywhere from $271,190 to $333,590 with the average total cash compensation of $295,590. Mr. Ryan managed Chases worldwide retail bank between 1984 and 1990. Prior to joining Regeneron, Ms. Tegan worked at Ciba Specialty Chemicals and then as senior director/head of procurement at Purdue Pharma L.P., where she held roles of increasing responsibility. Senior Vice President, Corporate Communications and Citizenship. Salary information comes from 1 data point collected directly from employees, users, and past and present job advertisements on Indeed in the past 24 months. She has been the chair of the Department of Molecular Biology and the Squibb Professor in Molecular Biology at Princeton University since 2003 and is a Howard Hughes Medical Institute investigator. The average Regeneron hourly pay ranges from approximately $24 per hour for an Intern - Hourly to $148 per hour for a Director. Were proud to be named a Glassdoor Best Places to Work 2023 in the U.S. Average salary for Pfizer Vice President Business Development in Chataignier, LA: [salary]. to let us know you're having trouble. Takeda Earlier in her career, Ms. Paull served in progressively senior human resources roles at DENYSPLY International. She is a former executive-in-residence in the Department of Management and Human Resources and former dean and John W. Berry, Sr. Read what they think about their salaries on our Compensation FAQ page for , Get started with your Free Employer Profile, Vice President salaries - 1 salaries reported. at Saint Johns University. , Chief Diversity, Equity and Inclusion Officer. Bola Akinlade, M.D., FACP, joined Regeneron in 2015 and serves as senior vice president, clinical development for Regenerons immunology and inflammation (I&I) portfolio. Prior to that, Dr. Herman completed his residency and postdoctoral training at University of California, San Francisco and was an assistant professor there before joining industry. As on 2021. The total cash compensation, which includes bonus, and annual incentives, can vary anywhere from $427,990 to $618,190 with the average total cash compensation of $507,290. Average salary for AstraZeneca Human Resources Vice President in Beckton, England: [salary]. Chair, Department of Molecular Biology, and Squibb Professor in Molecular Biology, Princeton University. Abbott It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. The highest-paying job at Regeneron is a Senior Director with a salary of $376,244 per year. Regental Professor and Chairman, Department of Molecular Genetics, The University of Texas Southwestern Center at Dallas. , Senior Vice President and Site Head, IOPS Raheen. Please enable Cookies and reload the page. He received his Ph.D. in medicine and molecular biology from Kings College, University of Cambridge and his M.D. Prior to joining Regeneron, Mr. Drosman worked at Pfizer for 12 years holding various positions of increasing responsibility in pharmacovigilance, quality assurance and regulatory strategy. Mr. Husseini received his undergraduate degree in molecular biology from Princeton University and MBA from the Wharton School at University of Pennsylvania. George D. Yancopoulos, MD, PhD Co-Founder, President and Chief Scientific Officer View bio Corporate Leaders Zoran Berkovic Senior Vice President, Financial Planning and Analysis View bio Maya Bermingham Senior Vice President, Public Policy and Government Affairs View bio Christina Chan Senior Vice President, Global Medical Affairs. This information is according to proxy statements . from Hibernia College. Lynn Macdonald, Ph.D., joined Regeneron in 1999 and serves as senior vice president, research. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. Sally A. Paull joined Regeneron in 2016 and now serves as executive vice president, human resources. John Lin, M.D., Ph.D., joined Regeneron in 2016 and oversees the preclinical bispecific antibody research work in research and development across all disease areas. Before joining Regeneron, Dr. Hirshberg was executive vice president, chief medical officer and head of global development at BOL Pharma, a biotech developing medical cannabis therapeutics, where he directed preclinical and clinical development, regulatory, pharmacovigilance and medical affairs. Dr. Thompson is a member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the Association of American Physicians. Regeneron salary trends based on salaries posted anonymously by Regeneron employees. Since joining the company, she has focused her efforts on evolving the compliance program and organizational structure to better support global expansion, as well as creating a new compliance risk navigation & advisory services group to better integrate compliance across the business. Dr. Lancaster received his BSc in pharmacology and his M.D. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives. Based on 1 salaries posted anonymously by Pfizer Vice President Business Development employees in Chataignier, LA. Dr. Prior to Inova, Ms. Paull was senior vice president, chief human resources ocer at Forest Laboratories. Previously, he held roles and responsibilities at Regeneron across R&D and business development. The base salary for Vice President of Laboratory in companies like REGENERON PHARMACEUTICALS, INC. range from $271,190 to $329,890 with the average base salary of $295,590. He obtained his J.D. Ms. Ravetti leads the Global Pharmaceutical Legal Operations team, a multidisciplinary team providing legal advice on the clinical development and commercialization of Regenerons products,including advice on R&D, regulatory matters, market access, product launches, lifecycle planning, and healthcare law compliance. Prior to joining Regeneron, she worked at Raytheon Engineers & Construction, Genzyme Corporation and Repligen Corporation. Prior to joining Regeneron, Mr. Calabro spent 18 years at UST, Inc., where he held positions of increasing responsibility within internal audit, ultimately serving as director of internal. degree from New York University. Senior Vice President, Associate General Counsel. Regeneron employees rate the overall compensation and benefits package 4.2/5 stars. per informarci del problema. He previously held roles on the tax teams at Arthur Anderson, Ernst & Young, and Diageo, and he currently serves as secretary and member of the board of trustees at Intensive Therapeutics, a 501c3 non-profit organization that provides therapy services to children with special needs. las molestias. in biochemistry and cell biology from the University of California, San Diego, and his M.D. Made up of our founding scientists, industry experts, Nobel Laureates and members of the National Academy of Sciences, we consistently push the boundaries of scientific excellence and discovery. He is the former president, chief executive officer, and chair of the board of Merck & Co., Inc., and is a member of the National Academy of Sciences, the National Academy of Medicine and the American Philosophical Society. She also held a number of roles within Novartis Oncology, including head of U.S. ethics, risk & compliance, head of global integrity & compliance, ad interim, and senior legal counsel. He received his B.S. Previously, Dr. Olson was a scientist at MicroGeneSys and Johnson & Johnsons RW Johnson Pharmaceutical Research Institute. Dr. Zoghbi has been a director of the company since 2016. Senior Vice President, Preclinical Manufacturing and Process Development. Prior to joining J&J, Christina worked in financial and corporate communications for Biogen and at Boehringer Ingelheim in various pharmaceutical sales and communications roles. He trained in internal medicine at Harvard Medical Schools Brigham Hospital and Bostons University Hospital. Prior to working at Regeneron, Mr. in biology from the State University of New York at Binghamton and an M.S. Nouhad Husseini joined Regeneron in 2011 and is head of business development, overseeing the companys efforts to execute new strategic collaborations and licensing agreements. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. Dr. Zambrowicz received his B.S. Dr. Schleifer is a licensed physician and is certified in neurology by the American Board of Psychiatry and Neurology. Average salary for AstraZeneca Vice President Finance in Seaham, England: [salary]. Retired Chairman of the Board and Chief Executive Officer, Prudential Financial, Inc. Mr. Ryan has been a director of the company since 2003. Prior to Merus N.V., he spent a decade at Novartis in various roles of increasing responsibility, ultimately overseeing the clinical strategy for their immuno-oncology portfolio. William Olson, Ph.D., joined Regeneron in 2013 as vice president and now serves as senior vice president of therapeutic proteins, where he is responsible for antibody generation, a key component of drug discovery, through innovative technologies. Gary Herman, M.D., joined Regeneron in 2015 and leads the early clinical development and experimental sciences (ECDES) function. at the State University of New York at Albany and a J.D. Mr. OLeary received his B.S. Dr. Brown has been a director of the company since 1991. Aris Baras, M.D., joined Regeneron in 2011 and helped found the Regeneron Genetics Center (RGC), where he now serves as senior vice president. The top 10% of employees earn more than $139k per year. Prior to joining Johnson & Johnson, Ms. Poon held senior leadership positions at Bristol-Myers Squibb Company, including president of international medicines and president of medical devices. The "Most Likely Range" represents values that exist within the 25th and 75th percentile of all pay data available for this role. CA. From 1998 until 2004, he held various managerial positions in the health and life sciences practice at Accenture, Ltd., a management consulting business. Senior Vice President, Immuno-Oncology and Head of Bispecifics. Dr. Olson received his B.S. It is especially meaningful that this award is based in part on the quality and consistency of employee reviews on Glassdoor. Boaz Hirshberg, M.D., MBA, joined Regeneron in 2021 and serves as senior vice president, clinical sciences general medicine, leading strategic program direction and late stage clinical development for a broad range of therapeutic areas including ophthalmology, cardiovascular and metabolic, pain and neurology, and infectious and rare diseases. Mr. Yocums broad knowledge and expertise in Good Manufacturing Practices (GMP) and processes have contributed to the successful launch of every Regeneron commercial product. In March, Christos Kyratsous, vice president for infectious disease research and viral vector technologies at Regeneron, told Vox that this treatment could also be used prophylactically to. Gilead Pfizer Based on 1 salaries posted anonymously by AstraZeneca Human Resources Vice President employees in Beckton, England. Senior Vice President, Chief Compliance Officer. This recognition is possible thanks to our dedicated colleagues, cutting-edge work and a culture that promotes limitless possibilities. , Bob McCowan is senior vice president and chief information officer at Regeneron. Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. and MBA from Iona College. The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. He completed his post-doctoral studies at the University of Pennsylvania. The estimated base pay is $208,589 per year. #GlassdoorBPTW, We are excited to share that for the second year in a row, BioSpace has named us a Best Place to Work. Dr. Hughes worked for Sunovion Pharmaceuticals, FORUM Pharmaceuticals, and spent 14 years at Pfizer, where she held various roles of increasing responsibility. Robert E. Landry joined Regeneron in 2013 and serves as executive vice president, finance and chief financial officer. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). Executive Vice President, Functional Genomics and Chief VelociGene Operations. from Cornell University and a J.D. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. from Douglass College of Rutgers University and a Ph.D. from the University of North Carolina at Chapel Hill. Glassdoor provides our best prediction for total pay in today's job market, along with other types of pay like cash bonuses, stock bonuses, profit sharing, sales commissions, and tips. In his time at the company, he has led the gene discovery and bioinformatics and target discovery groups. Senior Vice President, Drug Safety and Pharmacometrics. in computer engineering from Columbia University, his MBA from the McDonough School of Business at Georgetown University and his M.D. Dr. Yancopoulos was the 11th most highly cited scientist in the world in the 1990s, and in 2004, he became a member of the National Academy of Sciences. Having joined the company in 1999, Dr. Chen has held scientific roles of increasing responsibility over his 23 years with Regeneron. from Virginia Polytechnic Institute and State University. Salary information comes from 1 data point collected directly from employees, users, and past and present job advertisements on Indeed in the past 24 months. He served as president and chief executive officer of Memorial SloanKetteringCancer Center (MSK) from 2010 until September 2022 and continues to oversee the Craig Thompson Lab, which studies cellular metabolism and its role in disease. Prior to BOL, he spent 12 years at AstraZeneca/MedImmune in roles of increasing responsibility, ultimately building and overseeing the cardiovascular renal and metabolism clinical therapeutic area at MedImmune. Regental Professor of Molecular Genetics and Internal Medicine, Director, Erik JonssonCenter for Molecular Genetics, The University of Texas Southwestern Medical Center at Dallas. . Alessandra Ravetti, J.D., joined Regeneron in 2012 and serves as senior vice president, associate general counsel. This report is not for commercial use. Sing has been a director of the company since 1988. and BBA in finance and economics abroad and his MBA at Temple University. He received his B.S. Senior Vice President, Clinical Sciences General Medicine. , In addition to leading manufacturing operations in New Yorks capital region, Mr. Yocums sphere of influence extends beyond manufacturing to encompass all aspects of our quality culture. , Dr. Weinreich also previously served as vice president of clinical affairs at Gene Logic and as an independent consultant, helping small- to mid-stage biotechnology companies with drug commercialization. from New York University. He has been the president of Stanford University since 2016. Dr. Zoghbi is a member of the National Academy of Sciences, the Institute of Medicine, and the American Association for the Advancement of Science. Were proud to be named a Glassdoor Best Places to Work 2023 in the U.S. Prior to joining Regeneron, Ms. Ravetti spent 10 years at Pfizer in various positions of increasing responsibility, and she was previously an Associate at the law firm of Sullivan and Cromwell. He completed his medical residency at North Shore Long Island Jewish (LIJ) Health System and conducted post doctorate work at Columbia University. in molecular biology at the University of Wisconsin, and his Ph.D. in human genetics from Columbia University, College of Physicians and Surgeons. He received post graduate clinical training in OBGYN and gynecologic oncology at the University of Cambridge and Duke University Medical Center. Prior to joining Regeneron, Mr. Landry served as senior vice president and treasurer of Pfizer Inc. Mr. Landry also held a variety of U.S. and international financial and general management positions at Wyeth Pharmaceuticals, Pfizer and PricewaterhouseCoopers LLP, including at Wyeth's Australian and New Zealand affiliates. VA. and Ph.D. in chemical engineering from the University of Virginia. Snow built his expertise at various pharmaceutical and healthcare companies including AstraZeneca, Bristol Myers Squibb, Eloxx Pharmaceuticals and Radius Health. Senior Vice President, IOPS Finance and Business Operations. Caso continue recebendo esta mensagem, from University at Albany. GSK Prior to joining Fisher, Ms. Poon was vice chair, worldwide chair of pharmaceuticals, member of the executive committee and director at Johnson & Johnson.
